Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in managing and understanding uveitis.

Shih-Chou Chen1, Shwu-Jiuan Sheu2

  • 1Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

F1000Research
|March 31, 2017
PubMed
Summary

Recent advances in uveitis management include new biological immunosuppressive therapies and steroid implants. Timely treatment is crucial to prevent irreversible vision loss from this sight-threatening inflammatory eye disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and disease patterns of uveitis in Taiwan: A nationwide multicenter analysis.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Correction: Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study.

Ophthalmology and therapy·2026
Same author

Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study.

Ophthalmology and therapy·2026
Same author

Epiretinal membrane peeling in eyes with pseudophakia: prognostic and morphological factors of visual outcomes.

BMC ophthalmology·2025
Same author

Associations Between Initial Glycated Hemoglobin at Diabetes Diagnosis, Longitudinal Changes and Medication Effects, and the Severity and Progression of Sight-Threatening Diabetic Retinopathy.

The Kaohsiung journal of medical sciences·2025
Same author

Six-year findings of polypoidal choroidal vasculopathy in the EVEREST II study: Japanese subgroup analysis.

Japanese journal of ophthalmology·2025

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Uveitis is a significant cause of vision loss, primarily affecting working-age adults.
  • Prompt and effective management is essential to prevent irreversible visual impairment.

Purpose of the Study:

  • To review recent advancements in uveitis understanding and treatment since 2014.
  • To highlight new therapeutic strategies and diagnostic tools.

Main Methods:

  • Literature review of studies published since 2014.
  • Focus on novel immunosuppressive therapies, local steroid treatments, and advanced imaging techniques.

Main Results:

  • Introduction of biological agents as a new class of immunosuppressive therapy.
  • Development and application of local steroid implants for sustained drug delivery.
Keywords:
immunosuppressive therapyocular implantsoptical coherence tomography (OCT)uveitis

Related Experiment Videos

  • Advancements in imaging modalities for more accurate uveitis evaluation.

    • Conclusions:

    • New treatment options offer improved management for uveitis patients.
    • Continued research is vital for further understanding and combating this complex condition.